Bexarotene Capsule
Product Images NDC 31722-380

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bexarotene (NDC 31722-380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

75mg-cr (75mg Cr)

75mg-cr (75mg Cr)
This text provides information about Bexarotene capsules containing 75 mg per capsule. It advises keeping the capsules out of reach, storing at 20-25°C, avoiding exposure to high temperatures and humidity, protecting from light, and following the usual dosage instructions as provided on the package. It includes the National Drug Code (NDC) numbers 31722-380-01 and mentions that pertinent information is available at the center seam.*
FDA Label Image

75mg-cl (75mg Cl)

75mg-cl (75mg Cl)
This text provides information about Bexarotene Capsules in 75 mg strength, containing 100 capsules per pack. It includes details on the active ingredient, inactive ingredients, capsule shell composition, storage instructions, dosage guidance, and precautions. The product is prescribed and should be kept at a controlled room temperature, away from high temperatures, humidity, and light. The manufacturer is Ascent Pharmaceuticals, Inc., located in Central Islip, NY, and the product is distributed by Camber Pharmaceuticals, Inc., based in Piscataway, NJ. For more detailed patent information, visit www.camberpharma.com/medication-guides.*
FDA Label Image

Bexarotene (Bexarotene Capsules 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.